Gür-Çetinkaya, Pınar, et al. “Advantage of the Subcutaneous Immunoglobulin Replacement Therapy in Primary Immunodeficient Patients With or Without Secondary Protein Loss”. The Turkish Journal of Pediatrics, vol. 60, no. 3, June 2018, pp. 270-6, https://doi.org/10.24953/turkjped.2018.03.006.